arrow_back Back Filing freshness 10-Q FY 2024 SEC EDGAR

download Export Data

Traws Pharma, Inc.

TRAW

$0.55 ▼ -0.02 (-3.16%) at close

16 Visible periods

28 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Traws Pharma, Inc. shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $4.5M

Dividend Yield —

Revenue Growth 1134.5%

Op. Margin None

ROIC None

FCF / Share $-2.21 ↗

Trailing P/E 0.7x

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 5, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.79M

↑ +1134.5% —

Net Income Profit after all expenses

$9.17M

↑ +105.5% —

Operating Margin Operating profit as % of sales

-427.4%

↓ -104.2% —

FCF / Share Free cash flow per share

$-2.21

↑ +88.5% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of -1.98x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗	FY 2017 Dec 31, 2018 10-K ↗	FY 2016 Dec 31, 2017 10-K ↗	FY 2015 Dec 31, 2016 10-K ↗	FY 2014 Dec 31, 2015 10-K ↗	FY 2013 Dec 31, 2014 10-K ↗	FY 2012 Dec 31, 2013 10-K ↗	FY 2011 Dec 31, 2012 10-K ↗	FY 2010 Dec 31, 2011 10-K ↗	FY 2009 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	1134.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+14081%)	0.0% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	-2.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-127%)	-89.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1218%)	77.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+872%)	56.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+600%)	-85.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1173%)	-51.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-745%)	1332.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16550%)	-83.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1140%)	-89.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1221%)	3006.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+37478%)	—	—
EPS Growth YoY (%)	N/M	-56.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.8% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	5.2% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	55.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-778.8% Weak ↓ Weak Declining Year-over-year change in net income	0.1% Caution ↓ Caution Declining Year-over-year change in net income	-17.3% Weak ↓ Weak Declining Year-over-year change in net income	35.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-17.0% Weak ↓ Weak Declining Year-over-year change in net income	-4.5% Weak ↓ Weak Declining Year-over-year change in net income	14.6% Fair ↓ Fair Declining Year-over-year change in net income	-22.5% Weak ↓ Weak Declining Year-over-year change in net income	18.0% Good ↑ Good Improving Year-over-year change in net income	62.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.8% Weak ↑ Weak Improving Year-over-year change in net income	-109.1% Weak Weak Year-over-year change in net income	-13.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	88.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	10.2% Fair ↓ Fair Declining Year-over-year change in free cash flow	-9.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	32.7% Excellent Excellent Year-over-year change in free cash flow	41.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	131.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	0.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-0.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-53.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-43.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-33.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-26.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-52.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-0.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	5.3% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	-37.2% Weak Weak Compound annual revenue growth over 3 years	-18.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	64.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-36.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-28.7% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-22.1% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-47.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-54.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	22.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-23.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-55.7% Weak Weak Compound annual revenue growth over 5 years	30.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗	FY 2017 Dec 31, 2018 10-K ↗	FY 2016 Dec 31, 2017 10-K ↗	FY 2015 Dec 31, 2016 10-K ↗	FY 2014 Dec 31, 2015 10-K ↗	FY 2013 Dec 31, 2014 10-K ↗	FY 2012 Dec 31, 2013 10-K ↗	FY 2011 Dec 31, 2012 10-K ↗	FY 2010 Dec 31, 2011 10-K ↗	FY 2009 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	-427.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2949%)	-209.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1495%)	—	—	-48.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-422%)	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	-354.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3055%)	-209.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1844%)	—	—	-64.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-640%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	-285.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	-1.98x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗	FY 2017 Dec 31, 2018 10-K ↗	FY 2016 Dec 31, 2017 10-K ↗	FY 2015 Dec 31, 2016 10-K ↗	FY 2014 Dec 31, 2015 10-K ↗	FY 2013 Dec 31, 2014 10-K ↗	FY 2012 Dec 31, 2013 10-K ↗	FY 2011 Dec 31, 2012 10-K ↗	FY 2010 Dec 31, 2011 10-K ↗	FY 2009 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	—	—	—	—	—	—	-148.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-341.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	173.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-435.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-189.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-221.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	11.1% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-168.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-570.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-125.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-91.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-129.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-516.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-102.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-102.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-134.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-26.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	—	—	—	—	—	-185.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1339%)	—	206.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1274%)	—	-239.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1697%)	-279.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1966%)	-77.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-619%)	18.9% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+26%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗	FY 2017 Dec 31, 2018 10-K ↗	FY 2016 Dec 31, 2017 10-K ↗	FY 2015 Dec 31, 2016 10-K ↗	FY 2014 Dec 31, 2015 10-K ↗	FY 2013 Dec 31, 2014 10-K ↗	FY 2012 Dec 31, 2013 10-K ↗	FY 2011 Dec 31, 2012 10-K ↗	FY 2010 Dec 31, 2011 10-K ↗	FY 2009 Dec 31, 2010 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	-31872.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15555.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.59x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1451.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	—	—	$-38.52M	—	—	—	—	—	—	$-19.80M	$-43.58M	$-60.01M	$-81.53M	$-2.71M	$-7.34M

📊 What does each share earn? 6 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗	FY 2017 Dec 31, 2018 10-K ↗	FY 2016 Dec 31, 2017 10-K ↗	FY 2015 Dec 31, 2016 10-K ↗	FY 2014 Dec 31, 2015 10-K ↗	FY 2013 Dec 31, 2014 10-K ↗	FY 2012 Dec 31, 2013 10-K ↗	FY 2011 Dec 31, 2012 10-K ↗	FY 2010 Dec 31, 2011 10-K ↗	FY 2009 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$0.34	$0.15	$0.27	$0.27	$0.34	$0.50	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.83	$-35.21	$-22.57	$-22.75	$-24.00	$-54.25	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.21	$-19.19	$-21.38	$-19.48	$-28.94	$-49.75	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	—	—	—	—	—	—	$2.60	$23.73	$-407.02	$3.56K	—	—	—	—	—	—
Tangible Book Value per Share (USD)	—	—	—	—	—	—	$2.60	$23.73	$-407.02	$3.56K	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	8.23M	1.55M	839,554	836,329	673,288	464,096	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗	FY 2017 Dec 31, 2018 10-K ↗	FY 2016 Dec 31, 2017 10-K ↗	FY 2015 Dec 31, 2016 10-K ↗	FY 2014 Dec 31, 2015 10-K ↗	FY 2013 Dec 31, 2014 10-K ↗	FY 2012 Dec 31, 2013 10-K ↗	FY 2011 Dec 31, 2012 10-K ↗	FY 2010 Dec 31, 2011 10-K ↗	FY 2009 Dec 31, 2010 10-K ↗
Working Capital (USD)	$-3.17M	$13.42M	$13.44M	$31.30M	$49.31M	$9.76M	$15.18M	$9.33M	$-5.07M	$12.91M	$15.58M	$36.65M	$94.05M	$57.87M	—	—
Total Equity (USD)	—	—	—	—	—	—	$11.57M	$5.39M	$-11.69M	$4.30M	$10.01M	$22.75M	$80.41M	$-158.31M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2024 Dec 31, 2025 10-K ↗	FY 2023 Dec 31, 2024 10-K ↗	FY 2022 Dec 31, 2023 10-K ↗	FY 2021 Dec 31, 2022 10-K ↗	FY 2020 Dec 31, 2021 10-K ↗	FY 2019 Dec 31, 2020 10-K ↗	FY 2018 Dec 31, 2019 10-K ↗	FY 2017 Dec 31, 2018 10-K ↗	FY 2016 Dec 31, 2017 10-K ↗	FY 2015 Dec 31, 2016 10-K ↗	FY 2014 Dec 31, 2015 10-K ↗	FY 2013 Dec 31, 2014 10-K ↗	FY 2012 Dec 31, 2013 10-K ↗	FY 2011 Dec 31, 2012 10-K ↗	FY 2010 Dec 31, 2011 10-K ↗	FY 2009 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$2.79M	$226.00K	$226.00K	$226.00K	$226.00K	$231.00K	$2.18M	$1.23M	$787.00K	$5.55M	$11.46M	$800.00K	$4.75M	$46.19M	$1.49M	—
Depreciation Expense (USD)	$61.00K	$12.00K	$16.00K	$14.00K	$14.00K	$13.00K	$14.00K	$55.00K	$88.00K	$96.00K	$150.00K	$434.00K	$446.00K	$319.00K	$316.00K	—
Net Income, GAAP (USD)	$9.17M	$-166.52M	$-18.95M	$-18.96M	$-16.16M	$-25.16M	$-21.50M	$-20.57M	$-24.09M	$-19.67M	$-23.98M	$-63.68M	$-62.54M	$-29.91M	$-26.29M	—
Operating Cash Flow (USD)	$-18.18M	$-29.79M	$-17.93M	$-16.29M	$-19.49M	$-23.07M	$-20.83M	$-22.70M	$-23.82M	$-15.81M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 58 quarters

Traws Pharma, Inc.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare TRAW with peers